Objectives The use of drugs beyond their marketing authorisation, that is, off-label use, is
common practice in palliative care with over 70% of off-label use having little or no scientific …

Background: Drug use beyond the licence (off-label use, off-label drug use) is a common
practice in palliative care and respective recommendations can often be identified in the …

Background: Regulatory bodies including the European Medicines Agency register
medications (formulation, route of administration) for specific clinical indications. Once …

Background: The 'off-label'use of a drug beyond the specifications of its Marketing
Authorization is widespread in palliative care. It is legal, but there are implications for …

Background: Off-label-use is an indispensable element of palliative medicine. Up to one
third of all drugs are prescribed beyond their licence. It is challenging to find the right …

Methods A cross-sectional study was carried out. Informed consent was obtained from
patients admitted to 20 beds at a Home Care Unit for a 6 month period. Demographic and …

Off-label prescription is part of routine care in palliative medicine, but no information is
available about the situation in Italy. A cross-sectional observational survey was undertaken …

Background: The Delphi technique is widely used for the development of guidance in
palliative care, having impact on decisions with relevance for patient care. Aim: To …

Patients with a limited life expectancy use many medications, some of which may be
questionable. Objectives To identify possible solutions for difficulties concerning medication …

A drug prescription is usually the conclusion of a complex mental process that requires
knowledge, experience and insight. It also involves a degree of risk: doctors and other …